Advertised vs Actual Tirzepatide Prices

What we compared

For every program where we could reach the provider's own pricing page, we recorded the all-in monthly cost at a 10 mg maintenance dose — medication plus any mandatory recurring fee — and set it against the figure we had been carrying from third-party round-ups. Both numbers are on the same basis and at the same dose, which is the only way the comparison means anything.

The four mechanisms, in order of how much damage they do

Mandatory memberships excluded. The largest single distortion. Ivim advertises compounded tirzepatide from $133 a month and requires a $74.99 membership for the duration of the plan; the real entry cost is about $208. Mochi is $199 plus $79. Eden is its medication price plus $99. A round-up that prints the medication figure alone understates by the full membership, every month, forever.

Promotional first months printed as standing rates. Sprout Health appears widely at $199; its own site states $299, with $199 as a first-month promotion. Embody's $99 and $119 figures behaved the same way against a checkout rate captured at $349. You pay the promotional rate once and the standing rate eleven times.

Prepaid bundle rates quoted as monthly rates. A twelve-month prepayment discount is real, but it is not what a month-to-month patient pays, and it requires putting a four-figure sum at risk before you know whether you tolerate the drug.

The wrong molecule entirely. Twice we found a program's semaglutide price published in its tirzepatide column. Yucca Health's widely republished $146 and Oak Longevity's $130 are both semaglutide figures. Semaglutide is consistently cheaper than tirzepatide, so this error always understates, and it is invisible unless you open the provider's page.

Why the errors never run the other way

If these were random transcription mistakes you would expect roughly half to overstate. None did. The explanation is structural: every one of the four mechanisms above produces a lower number than the truth, because every one of them is a marketing artefact. Advertisers publish their most flattering figure; aggregators copy the advertised figure; readers compare aggregators.

The practical consequence for anyone shopping is that the cheapest options in any round-up are the ones most likely to be wrong, because the distortions cluster at the bottom of the table. The programs at the expensive end have less to gain from a flattering headline.

What this costs a real patient

Across the corrected records the average understatement is $124 a month. On a twelve-month course that is $1,484 more than the figure someone budgeted from, and the withdrawal evidence says treatment should be planned in years rather than months. Someone who chose a program on a $199 headline that is actually $299 has mis-budgeted by $1,200 a year.

How to check a price yourself in two minutes

1. Open the provider's own pricing page, not a review of it.
2. Find the figure at 10 mg, not the starting dose.
3. Look for a separate membership, platform or consultation fee and add it.
4. Check whether the number is a first-month promotion or a prepaid-term rate.
5. Ask, in writing, whether that rate holds at renewal.

Every price on this site carries a verification status saying whether we have done that, and the verification ledger lists what each figure was before we checked it.

Advertised vs Actual Tirzepatide Prices: the shortest useful summary

Tirzepatide is a once-weekly injection titrated from 2.5 mg to a 15 mg ceiling in 2.5 mg steps at intervals of at least four weeks, producing roughly 15 to 21% mean weight reduction across the studied maintenance arms at 72 weeks and about 20% against semaglutide's 14% in the only head-to-head trial. It works while it is taken; the withdrawal evidence shows substantial regain after stopping. Compounded preparations cost from $133 a month and are not FDA-approved; brand product is approved and costs considerably more.

Those five facts decide most questions people arrive with. Everything else on this page is detail underneath them — which is worth reading before you spend $2,388 on a first year, but not worth confusing with the outline.

Advertised vs Actual Tirzepatide Prices: where to go next

If you have not chosen a program, price your expected maintenance dose with the projector rather than reading advertisements. If you have, check what it charges at 10 mg against the price-by-dose table. If you are struggling with side effects, the side-effect reference covers each one with reported frequencies and the red flags that need a clinician. And if a program has refused to name its pharmacy, the verification walkthrough explains why that single answer outranks any price difference.